New discoveries in atherosclerosis pathways have shed light on the active mechanisms in other diseases such as chronic kidney disease (CKD) and HIV, paving the way for furture therapeutics.

Mohammad Ali Sheffeh, MD, from the Mayo Clinic in Rochester, Minnesota, and colleagues examined the efficacy of GLP-1 RA or SGLT-2i initiation for reducing mortality or cardiovascular events among ...

Left atrial appendage closure is an alternative strategy for stroke prophylaxis, Wazni and colleagues noted. "The safety and ...

PHILADELPHIA- Polygenic risk scores (PRSs) are a cutting-edge tool in genetics, combining information from genetic markers across the genome to ...

Researchers sought to determine if there is an association between attendance in cardiac rehabilitation and the prevalence ...

A nasal spray would be a workaround for drug resistance seen with oral diuretics, with the potential to reduce hospital ...

Pharmacists who received active feedback about their heart failure patients increased the frequency of their patient interactions and prescribed more heart failure medication adjustments, according to ...

The SARAH trial was limited to high-risk patients, which the lead investigator said prevented unnecessary exposure to adverse ...

Researchers sought to determine the relationship between sleep duration and clinical depression in patients with cardiovascular disease.

Using an artificial intelligence program to read echocardiograms may reduce the wait time for results and help lead to more timely medical care, according to late-breaking science presented today at ...

While coronary heart disease and diabetes are often seen in the same patients, a diagnosis of diabetes does not necessarily ...

A widely used heart failure medication called sacubitril/valsartan was associated with a lower risk of heart damage compared ...